Skip to content
    SOTK
    Earnings call· Feb 2026(Q4 FY26)

    SONO TEK Q4 FY26 earnings call SOTK

    May 28, 2026 Source

    Executive summary

    Sono-Tek Q4 FY26 — Strong Profitability Expansion Driven by High-Value Systems

    Sono-Tek delivered a strong Q4 and full fiscal year 2026, marked by significant profitability expansion and consistent revenue performance. The company's strategic shift towards higher-value, high average selling price (ASP) production systems, particularly in the medical and microelectronics sectors, drove margin improvement and operating leverage. While clean energy demand softened, the company's diversification strategy allowed for continued growth, though future visibility is impacted by the lumpy nature of large system orders.

    Highlights

    5

    • FY26 revenue reached $20.9 million, marking the second consecutive year above $20 million and third consecutive year of annual growth.

    • Gross margin expanded to 51% for FY26, up from 48% in the prior year, driven by favorable product mix and increased U.S. sales.

    • Operating income grew 81% to $1.2 million for FY26, with operating margins improving to 9% from 5%.

    • Net income for FY26 increased 42% to $1.8 million, reflecting strong operating performance.

    • Medical sector revenue increased 54% year-over-year, driven by demand for balloon catheter coating systems and stent applications.

    Concerns

    4

    • Clean energy market declined 19% in FY26 due to reduced electrolysis demand and policy shifts.

    • Full-year fiscal 2027 revenue is expected to be relatively flat to modestly higher compared to FY26.

    • Visibility beyond the first half of FY27 remains limited due to uncertainty in clean energy and unpredictable timing of high ASP customer orders.

    • International markets were mixed with softness in Asia and Latin America in FY26.

    Guidance & targets

    2
    CategoryTargetConfidence
    Revenue growth and profitability
    Continued growth and profitability
    medium materiality
    High
    Full-year revenue
    Relatively flat to modestly higher
    high materiality
    Medium

    Segment performance

    9
    SegmentRevenueYoYQoQMargin
    Medical
    Driven by strong demand for balloon catheter coating systems, stent applications, and other advanced medical technologies.
    		—54%——
    Electronics
    Supported by electronically active coatings for diagnostic-related devices.
    		—16%——
    Clean Energy
    Reflecting reduced electrolysis demand due to policy shifts, partially offset by solar-related system shipments earlier in the fiscal year.
    		—-19%——
    Industrial
    Commonly shows variability in demand on large glass coating orders.
    		—declined——
    Integrated coating systems (in-line coating systems)
    Driven by solar-related systems.
    		—91%——
    Multi-access systems
    Due to lower clean energy demand.
    		—declined——
    Flexing systems
    Supported by strong Asia demand.
    		—53%——
    U.S. and Canada
    Driven by shipments of 5 high ASP systems totaling $3.85 million. Benefits revenue growth and margins due to reduced international related costs.
    		67% of total revenue12%——
    International markets
    Some softness in Asia and Latin America.
    		—mixed——

    Operational metrics

    20
    Gross Profit Growth
    15%YoY
    Q4 FY26

    For the fourth quarter.

    Net Income Growth
    70%YoY
    Q4 FY26

    For the fourth quarter.

    Gross Profit Growth
    8%YoY
    FY26

    For the full fiscal year.

    Operating Income Growth
    81%YoY
    FY26

    For the full fiscal year.

    Total Operating Expenses
    $8.7 millionrelatively flat YoY
    FY26

    For the full fiscal year.

    Research and Development Costs
    $2.55 milliondecreased 6% YoY
    FY26

    Primarily due to lower personnel and material costs.

    Sales and Marketing Costs
    $3.5 milliondecreased 4% YoY
    FY26

    Reflects lower commission and personnel costs.

    General and Administrative Costs
    $2.66 millionincreased 14% YoY
    FY26

    Driven by higher salaries, insurance, and stock-based compensation expense.

    Interest and Dividend Income
    $443,000slightly lower YoY
    FY26

    Due to reduced interest rates.

    Net Income Growth
    42%YoY
    FY26

    For the full fiscal year, reflecting strong operating performance and margin expansion.

    Cash, Cash Equivalents and Marketable Securities
    $14.8 millionincreased from $11.9 million prior year
    FY26 end

    Balance sheet item.

    Working Capital
    $16.2 million
    FY26 end

    Balance sheet item.

    Outstanding Debt
    0
    FY26 end

    Company has no outstanding debt.

    Headcount
    ~90
    Current

    Current operating headcount.

    Stock Repurchase Program Executed
    several hundred thousand dollars
    To date

    Minimal amount purchased back so far.

    High ASP Machine Price Range (Old)
    $400,000-$600,000
    Prior

    Typical price range for machines customers were buying previously.

    High ASP Machine Price Range (New)
    $1 million-$3 million
    Current

    Typical price range for new, more complex high ASP platforms.

    North America Revenue
    $14 millionup from $4.5 million in 2020
    FY26

    North America revenue growth from 2020 to FY26.

    Potential Revenue Increase from Large Order
    50-80%
    Future

    Impact of a single $10 million order on overall revenue trajectory.

    Headcount Growth for Double Revenue
    30-40%
    Future

    Estimated headcount increase if revenue output approximately doubles from current levels, reflecting operating leverage.

    Industry KPIs

    7
    MetricValueDetails
    Orders book to bill$9.12 millionUSD
    Segment revenue growthIntegrated coating systems (in-line): 91%; Multi-access systems: declined; Flexing systems: 53%%
    Design wins product cycle ramps300-millimeter wafer machine development
    Order visibility backlog policyBacklog supports visibility into FY27
    Capacity expansion internal sourcing$500,000-$600,000 investmentUSD
    End market revenue mix organic growthMedical: 54%; Electronics: 16%; Clean Energy: -19%; Industrial: declined%
    Operating margin incremental leverageGross Margin: 51%; Operating Margin: 9%%

    Orderbook & backlog

    1
    Backlog$9.12 millionFY26 end

    Remaining close to historically high levels, supporting visibility into fiscal 2027. Analyst noted book-to-bill of 0.44 and bookings of $2.5 million for the quarter, which management did not confirm.

    Product announcements

    1
    ProductTypeDetails
    300-millimeter wafer machineroadmap

    Capital programs

    2
    Mezzanine Structure Capacity Expansion (Phase 1)underway
    Period spend: $500,000-$600,000
    Start: Current calendar year

    Benefit: Increase practical annual revenue capacity to $35 million; improved operational efficiency

    Involves constructing a mezzanine structure and reconfiguring manufacturing space within the existing facility. Actively working with New York State economic development programs for support.

    Adjacent Space Capacity Expansion (Phase 2)under consideration

    Benefit: Expand overall capacity to approximately $45 million annual revenue

    Involves taking over adjacent space currently in a short-term leased building. This phase is under consideration following the first phase of expansion.

    Risks & headwinds

    4
    Clean energy market declineFY26

    19% decline in FY26

    Mitigation: Diversification into medical and electronics sectors, leveraging transferable machine integration capabilities.

    Limited visibility for second half of FY27H2 FY27

    Uncertainty in clean energy sectors and timing of high ASP customer orders

    Mitigation: Focus on driving higher ASP, more complex platforms; continuous engagement with customers on 'what next' to secure larger orders.

    Lumpy order flow from high ASP systemsOngoing

    Large orders ($1M-$3M) can create significant shifts in quarterly revenues and less predictable shipment timing

    Mitigation: Working towards increasing the frequency of large orders (e.g., once a month or more) in addition to normal flow business.

    International market softnessFY26

    Mixed performance with softness in Asia and Latin America

    Mitigation: Increased focus on the U.S. market, which grew 12% and represented 67% of total revenue, benefiting margins.

    Q&A highlights

    7

    What is the current order activity and segment mix within the backlog, given that prior backlog was heavily clean energy and now is expected to be medical and microelectronics?

    The backlog has significantly shifted from clean energy to medical and microelectronics, which are now the fastest-growing sectors. The company's machine integration capabilities developed for clean energy were transferable. Order flow is lumpier due to high ASP platforms ($1M-$3M machines), with a goal to increase the frequency of these large orders.

    “I can tell you this current fiscal year, it's very light clean energy related. It's really transitioned and shifted drastically over towards the medical sectors and the microelectronic sectors.”

    asked by Richard Ryan · answered by R. Harshbarger

    2 min read6 chapters

    Detailed Narrative

    01

    Strategic Shift to High-Value Systems

    Sono-Tek's strategic focus on higher-value, high average selling price (ASP) production systems has been successful, driving both revenue quality and margin expansion. This shift has enabled the company to maintain strong gross margins, consistently in the upper 40s to low 50s, even with more complex, integrated solutions. Customers are increasingly viewing Sono-Tek as a technology solutions and process expertise provider, willing to pay for integration expertise and turnkey solutions.

    02

    Market Diversification and Growth Drivers

    The company's diversification strategy proved effective, with strong growth in the Medical sector (up 54% YoY) and Electronics (up 16% YoY), offsetting a 19% decline in Clean Energy. This was facilitated by transferring machine integration capabilities developed for clean energy to other markets. The U.S. market was a standout performer, growing 12% and representing approximately 67% of total revenue, benefiting both revenue growth and margins due to reduced international costs.

    03

    Backlog and Order Dynamics

    Sono-Tek ended FY26 with a solid backlog of $9.12 million, supporting visibility into FY27. The nature of orders has become lumpier due to larger, more complex, high ASP platforms, with individual machines now ranging from $1 million to $3 million, up from $400,000-$600,000 previously. This can significantly impact quarterly revenues and shift delivery timelines, making longer-term visibility challenging.

    04

    Semiconductor Market Progress

    The company is making progress in the 300-millimeter wafer market for fabs, with significant effort invested in development over the last year. A new 300-millimeter machine is planned for introduction at Semicon Europe by the end of the calendar year. This initiative is expected to contribute to revenue in FY28, driven by customer demand for their product in this market.

    05

    Capacity Expansion Plans

    Sono-Tek is proactively pursuing manufacturing expansion, starting with a $500,000 to $600,000 investment in a mezzanine structure within its existing facility. This first phase is expected to increase annual revenue capacity to $35 million and improve operational efficiency. An additional expansion phase, utilizing adjacent leased space, is under consideration and could further expand overall capacity to approximately $45 million.

    06

    Headcount and Operational Leverage

    While revenue is expected to grow, headcount is projected to increase at a slower rate, estimated at 30-40% for a doubling of revenue, reflecting operating leverage and scalability. The majority of hiring would occur in manufacturing operations, alongside continued growth in the field deployed engineering team. The company is also aggressively adopting AI and automation tools to improve scalability and efficiency across various functions.

    AI-generated summary of the company’s earnings call. Not investment advice.